Loading
Latest filing published 07 Aug 2026 for Braveheart Bio, Inc., €17k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Michele A. Anderson is known so far (7 August 2026): an open-market purchase, €17k, in Braveheart Bio, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration